Ligand Pharmaceuticals (LGND) Receives $1 Million Milestone Payment From Merck (MRK) Subsidiary
Tweet Send to a Friend
Ligand Pharmaceuticals (NASDAQ: LGND) has received a $1 million milestone payment from N. V. Organon, a subsidiary of Merck ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
